Symrise says pet nutrition slowed as pricing normalized: full analysis
Version 2
Symrise is reporting a temporary slowdown in pet nutrition, but not a collapse in demand. In first-quarter 2026 results released in late April, the company said Pet Nutrition posted a slight organic decline as prices continued to normalize, while volumes remained positive. That distinction matters: the softness appears to be coming from lower pricing rather than fewer units moving through the market. Symrise also reaffirmed its 2026 guidance, suggesting management sees the slowdown as manageable and temporary. (symrise.com)
The update comes after a period when pet food and ingredient companies benefited from inflation-related pricing tailwinds. In 2025, Symrise reported solid first-quarter growth in the same broad business segment, and industry data entering 2026 showed pet food prices remained elevated, even as the market became more value-conscious. That backdrop helps explain why “normalization” is now showing up in supplier results: companies are cycling past earlier price increases, while pet parents remain interested in premium nutrition but increasingly sensitive to cost. (petfoodindustry.com)
The company’s own numbers show a mixed but still constructive picture. Symrise reported group sales of about €1.249 billion in Q1 2026, with an organic sales decline of 0.4% year over year, better than it had anticipated. Within Taste, Nutrition & Health, sales reached €749 million and organic growth was 1.7%. Pet Food delivered low single-digit organic growth, supported by Pet Palatability, while Pet Nutrition slipped slightly on an organic basis because pricing kept normalizing despite positive volumes. (symrise.com)
Even with that near-term drag, Symrise is still putting capital behind pet nutrition. In February, it opened a new production facility in Querétaro to expand service for pet food customers in Mexico and strengthen its regional footprint. In April, it announced a strategic equity investment in Bond Pet Foods, a U.S. biotechnology company using precision fermentation to produce animal-identical proteins for pet food. Taken together, those moves suggest Symrise is preparing for longer-term growth by broadening both its manufacturing base and its ingredient pipeline. That’s an inference, but it’s well supported by the timing and focus of the company’s recent announcements. (petfood.symrise.com)
Industry commentary around pet food in 2026 points in a similar direction. Coverage from PetfoodIndustry has described a market balancing premiumization with growing value pressure, with experts noting that pet parents still want strong nutrition but may trade down or seek more affordable formats as economic uncertainty persists. Another recent market update found producer prices for pet food remained high early in 2026, underscoring the tension between cost pressure and consumer resistance to further price increases. (petfoodindustry.com)
Why it matters: For veterinary professionals, supplier updates like this can offer an early read on how the nutrition market is shifting behind the scenes. If ingredient pricing is stabilizing while volumes remain healthy, manufacturers may have more room to defend margins through reformulation, sourcing changes, or operational efficiencies instead of repeated price hikes. That could influence the availability, positioning, and pricing of therapeutic, premium, and sustainability-focused diets recommended in practice. Symrise’s investment in precision fermentation is also worth watching because alternative proteins and biotech-enabled ingredients may increasingly enter companion animal nutrition conversations, especially where sustainability, palatability, or supply resilience are priorities. (symrise.com)
What to watch: The next key signal will be whether Symrise’s pet nutrition pricing stabilizes over the next few quarters, and whether its Mexico expansion and Bond Pet Foods partnership begin to show up in new product launches, customer wins, or broader use of biotech-derived ingredients in pet diets. Symrise has reaffirmed its full-year 2026 outlook, so future quarterly updates should clarify whether this was a short-lived reset or the start of a more sustained margin and pricing recalibration across pet nutrition. (symrise.com)